Innoviva (INVA) Other Operating Expenses (2013 - 2023)
Innoviva (INVA) posted Other Operating Expenses of -$11.8 million for Q3 2023, down 132.06% on a QoQ basis from $36.7 million in Q2 2023, and up 96.04% year-over-year from -$6.0 million in Q3 2022.
Innoviva (INVA) Other Operating Expenses (2013 - 2023) Analysis & Trends
Innoviva's Other Operating Expenses history runs 6 years deep, the most recent figure standing at -$11.8 million for Q3 2023.
- Quarterly Other Operating Expenses rose 96.04% year-over-year to -$11.8 million in Q3 2023, while the trailing twelve-month figure through Jun 2024 was -$11.8 million (up 95.43% YoY) and the FY2022 annual result came in at -$60.6 million, up 13.67% from the prior year.
- Other Operating Expenses was -$11.8 million for Q3 2023 at Innoviva, down from $36.7 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $62.1 million in Q2 2022 and bottomed at -$296.7 million in Q3 2022.
- A 4-year average of -$40.6 million and a median of -$4.4 million in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses tumbled 150.99% — and 2023, when it soared 96.04%.
- Innoviva's Other Operating Expenses stood at -$33.1 million in 2020, then tumbled by 256.9% to -$118.2 million in 2021, then tumbled by 150.99% to -$296.7 million in 2022, then surged by 96.04% to -$11.8 million in 2023.
- Business Quant data shows INVA's Other Operating Expenses at -$11.8 million in Q3 2023, $36.7 million in Q2 2023, and $2.9 million in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -11.75 Mn |
| Jun 30, 2023 | 36.66 Mn |
| Mar 31, 2023 | 2.91 Mn |
| Sep 30, 2022 | -296.70 Mn |
| Jun 30, 2022 | 62.06 Mn |
| Mar 31, 2022 | 33.01 Mn |
| Sep 30, 2021 | -118.21 Mn |
| Dec 31, 2020 | -33.12 Mn |
| Mar 31, 2018 | 2.70 Mn |
| Mar 31, 2013 | -26.64 Mn |